• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中医调节肠道微生物群治疗糖尿病机制的研究进展。

Research progress on the mechanism of TCM regulating intestinal microbiota in the treatment of DM mellitus.

机构信息

College of Pharmacy, Jiamusi University, Jiamusi, Heilongjiang, China.

Heilongjiang Pharmaceutical Research Institute, Jiamusi, Heilongjiang, China.

出版信息

Front Endocrinol (Lausanne). 2024 Mar 27;15:1308016. doi: 10.3389/fendo.2024.1308016. eCollection 2024.

DOI:10.3389/fendo.2024.1308016
PMID:38601207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11004430/
Abstract

In recent years, with the improvement of people's living standards, the incidence of DM has increased year by year in China. DM is a common metabolic syndrome characterized by hyperglycemia caused by genetic, environmental and other factors. At the same time, long-term suffering from DM will also have an impact on the heart, blood vessels, eyes, kidneys and nerves, and associated serious diseases. The human body has a large and complex gut microbiota, which has a significant impact on the body's metabolism. Research shows that the occurrence and development of DM and its complications are closely related to intestinal microbiota. At present, western medicine generally treats DM with drugs. The hypoglycemic effect is fast and strong, but it can have a series of side effects on the human body. Compared with western medicine, Chinese medicine has its unique views and methods in treating DM. TCM can improve symptoms and treat complications by improving the imbalance of microbiota in patients with DM. Its characteristics of health, safety, and reliability are widely accepted by the general public. This article reviews the relationship between intestinal microbiota and DM, as well as the mechanism of TCM intervention in DM by regulating intestinal microbiota.

摘要

近年来,随着人们生活水平的提高,中国的糖尿病(DM)发病率逐年上升。DM 是一种常见的代谢综合征,其特征是由遗传、环境等多种因素引起的高血糖。同时,长期患有 DM 还会对心脏、血管、眼睛、肾脏和神经造成影响,并伴有严重的并发症。人体拥有庞大而复杂的肠道微生物群,其对人体的新陈代谢有着显著的影响。研究表明,DM 的发生和发展及其并发症与肠道微生物群密切相关。目前,西医一般采用药物治疗 DM,降糖作用迅速而强大,但会对人体产生一系列副作用。与西医相比,中医在治疗 DM 方面有其独特的观点和方法。中医可以通过改善 DM 患者肠道微生物群的失衡来改善症状并治疗并发症。其具有健康、安全、可靠的特点,被广大民众所接受。本文综述了肠道微生物群与 DM 的关系,以及通过调节肠道微生物群来干预 DM 的中医机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/7383ab633926/fendo-15-1308016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/f89ea4dbcc58/fendo-15-1308016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/7740ebd0b7d2/fendo-15-1308016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/b957f5cb2084/fendo-15-1308016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/0cc187d35bfb/fendo-15-1308016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/7383ab633926/fendo-15-1308016-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/f89ea4dbcc58/fendo-15-1308016-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/7740ebd0b7d2/fendo-15-1308016-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/b957f5cb2084/fendo-15-1308016-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/0cc187d35bfb/fendo-15-1308016-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e480/11004430/7383ab633926/fendo-15-1308016-g005.jpg

相似文献

1
Research progress on the mechanism of TCM regulating intestinal microbiota in the treatment of DM mellitus.中医调节肠道微生物群治疗糖尿病机制的研究进展。
Front Endocrinol (Lausanne). 2024 Mar 27;15:1308016. doi: 10.3389/fendo.2024.1308016. eCollection 2024.
2
Research progress on Traditional Chinese Medicine syndromes of diabetes mellitus.糖尿病中医证候研究进展。
Biomed Pharmacother. 2020 Jan;121:109565. doi: 10.1016/j.biopha.2019.109565. Epub 2019 Nov 5.
3
Review of the correlation between Chinese medicine and intestinal microbiota on the efficacy of diabetes mellitus.探讨中医与肠道微生物群在糖尿病疗效中的相关性。
Front Endocrinol (Lausanne). 2023 Jan 25;13:1085092. doi: 10.3389/fendo.2022.1085092. eCollection 2022.
4
The Gut Microbiota and Traditional Chinese Medicine: A New Clinical Frontier on Cancer.肠道微生物群与中医药:癌症的新临床前沿。
Curr Drug Targets. 2021;22(11):1222-1231. doi: 10.2174/1389450122666210412141304.
5
Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease.肠道微生物群:中医治疗代谢综合征的关键——以糖尿病和非酒精性脂肪性肝病为例
Front Immunol. 2022 Dec 23;13:1072376. doi: 10.3389/fimmu.2022.1072376. eCollection 2022.
6
New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes.新型抗高血糖药物和中药对 2 型糖尿病肠道菌群的新见解。
Drug Des Devel Ther. 2021 Nov 30;15:4849-4863. doi: 10.2147/DDDT.S334325. eCollection 2021.
7
An overview of traditional Chinese medicine affecting gut microbiota in obesity.中医对肥胖症中肠道微生物群影响的概述。
Front Endocrinol (Lausanne). 2023 Mar 1;14:1149751. doi: 10.3389/fendo.2023.1149751. eCollection 2023.
8
Prevention and treatment of chronic heart failure through traditional Chinese medicine: Role of the gut microbiota.通过中医药防治慢性心力衰竭:肠道微生物群的作用。
Pharmacol Res. 2020 Jan;151:104552. doi: 10.1016/j.phrs.2019.104552. Epub 2019 Nov 17.
9
Gut Microbiota, a Potential New Target for Chinese Herbal Medicines in Treating Diabetes Mellitus.肠道微生物群,中药治疗糖尿病的潜在新靶点。
Evid Based Complement Alternat Med. 2019 Feb 18;2019:2634898. doi: 10.1155/2019/2634898. eCollection 2019.
10
The Primary Mechanisms of Drug-Food Homologous Traditional Chinese Medicine Polysaccharides in the Prevention and Treatment of Diabetes.药物-食物同源中药多糖防治糖尿病的主要机制。
J Med Food. 2024 Aug;27(8):693-703. doi: 10.1089/jmf.2023.k.0093. Epub 2024 May 22.

引用本文的文献

1
The Therapeutic Effect and Mechanism of Traditional Chinese Medicine in Type 2 Diabetes Mellitus and Its Complications.中药对2型糖尿病及其并发症的治疗作用及机制
Diabetes Metab Syndr Obes. 2025 May 15;18:1599-1627. doi: 10.2147/DMSO.S517874. eCollection 2025.
2
Research progress in the treatment of an immune system disease-type 1 diabetes-by regulating the intestinal flora with Chinese medicine and food homologous drugs.通过药食同源药物调节肠道菌群治疗免疫系统疾病——1型糖尿病的研究进展
Biosci Microbiota Food Health. 2024;43(3):150-161. doi: 10.12938/bmfh.2023-068. Epub 2024 Feb 21.

本文引用的文献

1
Adenine's impact on mice's gut and kidney varies with the dosage administered and relates to intestinal microorganisms and enzyme activities.腺嘌呤对小鼠肠道和肾脏的影响因给药剂量而异,且与肠道微生物和酶活性有关。
3 Biotech. 2024 Mar;14(3):88. doi: 10.1007/s13205-024-03959-y. Epub 2024 Feb 22.
2
[Effect of Zuogui Jiangtang Jieyu Formula on intestinal flora and short-chain fatty acid metabolism in rats with diabetes mellitus complicated with depression].左归丸降糖解郁方对糖尿病合并抑郁症大鼠肠道菌群及短链脂肪酸代谢的影响
Zhongguo Zhong Yao Za Zhi. 2024 Jan;49(1):208-215. doi: 10.19540/j.cnki.cjcmm.20230908.401.
3
Gut microbiota: A new target for T2DM prevention and treatment.
肠道微生物群:T2DM 预防和治疗的新靶点。
Front Endocrinol (Lausanne). 2022 Aug 11;13:958218. doi: 10.3389/fendo.2022.958218. eCollection 2022.
4
Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial.白藜芦醇补充剂对超重 2 型糖尿病患者肝脂肪变性和心血管指数的影响:一项双盲、随机对照试验。
BMC Cardiovasc Disord. 2022 May 10;22(1):212. doi: 10.1186/s12872-022-02637-2.
5
Resveratrol Inhibits Metabolism and Affects Blood Platelet Function in Type 2 Diabetes.白藜芦醇抑制 2 型糖尿病患者的代谢并影响血小板功能。
Nutrients. 2022 Apr 14;14(8):1633. doi: 10.3390/nu14081633.
6
Gut Microbiota and Complications of Type-2 Diabetes.肠道微生物群与 2 型糖尿病并发症。
Nutrients. 2021 Dec 30;14(1):166. doi: 10.3390/nu14010166.
7
Intestinal microbiota and their metabolic contribution to type 2 diabetes and obesity.肠道微生物群及其对2型糖尿病和肥胖症的代谢作用。
J Diabetes Metab Disord. 2021 Aug 4;20(2):1855-1870. doi: 10.1007/s40200-021-00858-4. eCollection 2021 Dec.
8
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy.肠道微生物群失调及其在糖尿病视网膜病变中的意义
Front Cell Infect Microbiol. 2021 Mar 19;11:646348. doi: 10.3389/fcimb.2021.646348. eCollection 2021.
9
Unravelling the involvement of gut microbiota in type 2 diabetes mellitus.解析肠道微生物群在2型糖尿病中的作用
Life Sci. 2021 May 15;273:119311. doi: 10.1016/j.lfs.2021.119311. Epub 2021 Mar 1.
10
Alterations in the gut bacterial microbiome in people with type 2 diabetes mellitus and diabetic retinopathy.2 型糖尿病合并糖尿病视网膜病变患者肠道细菌微生物组的改变。
Sci Rep. 2021 Feb 2;11(1):2738. doi: 10.1038/s41598-021-82538-0.